Analysts await Nobilis Health Corp. (NASDAQ:HLTH) to report earnings on Mar, 15 for the fiscal quarter ending Dec 2015.

They expect $0.24 EPS, up 100% or $0.24 from last year’s $n/a per share.

At the moment 5 analysts are watching Nobilis Health Corp. (NASDAQ:HLTH), 4 rate it “Buy”, 1 “Outperform”, 0 “Underperform”, 0 “Sell”, while 0 “Hold”.

Looking forward, for the quarter ending Mar-16, 2 analysts have a mean sales target of 50.46 million. For the quarter ending Jun-16, 2 analysts have a mean sales target of 68.13 million whilst for the year ending Dec-16, 5 analysts have a mean target of 314.35 million.

In terms of earnings per share, 2 analysts have a 0.00 EPS mean target for the quarter ending Mar-16, for the quarter ending Jun-16, 2 analysts have a 0.05 EPS mean target and for the quarter ending Jun-16 there are 5 estimates of 0.36 EPS.

Total shares held by institutions as of the most recent company filings are 17,593,684 with a reported 2,023,377 bought and 1,580,506 sold. These holdings make up 24% of the company’s outstanding shares.

The stock increased 6.15% or $0.2 during the last trading session, hitting $4.90. Nobilis Health Corp. (NASDAQ:HLTH) has fallen 4.69% over the past 6 months and is downtrending.